JamesK.McCordMD
Cardiology • Detroit, MIAdult Congenital Heart Disease
Assistant Professor, Internal Medicine, Wayne State University School of Medicine
Dr. McCord is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Henry Ford Health System
2799 West Grand Boulevard
Detroit, MI 48202Phone+1 313-916-2436Fax+1 313-916-8907
Education & Training
Henry Ford Health/Henry Ford HospitalResidency, Internal Medicine, 1988 - 1991
The University of Toledo College of MedicineClass of 1988
Certifications & Licensure
MI State Medical License 1991 - 2025
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- 259 citationsMulticenter Evaluation of a 0-Hour/1-Hour Algorithm in the Diagnosis of Myocardial Infarction With High-Sensitivity Cardiac Troponin T.Christian Mueller, Evangelos Giannitsis, Michael Christ, Jorge Ordonez-Llanos, Christopher DeFilippi
Annals of Emergency Medicine. 2016-07-01 - 45 citationsPerformance of Novel High-Sensitivity Cardiac Troponin I Assays for 0/1-Hour and 0/2- to 3-Hour Evaluations for Acute Myocardial Infarction: Results From the HIGH-US S...Richard M. Nowak, Robert H. Christenson, Gordon Jacobsen, James McCord, Fred S. Apple
Annals of Emergency Medicine. 2020-07-01 - 28 citationsDiagnostic Performance of High-Sensitivity Cardiac Troponin T Strategies and Clinical Variables in a Multisite US Cohort.Brandon Allen, Robert H. Christenson, Scott Cohen, Richard M. Nowak, R. Gentry Wilkerson
Circulation. 2021-04-27
Press Mentions
Comparative Risk of Myocarditis/Pericarditis Following Second Doses of BNT162b2 and mRNA-1273 Coronavirus VaccinesNovember 1st, 2022- ACC Advocacy: Engage, Influence, AdvocateOctober 13th, 2022
Cardiovascular Drug Interactions with Nirmatrelvir/Ritonavir in Patients with COVID-19: JACC Review Topic of the WeekOctober 12th, 2022- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
